A stochastic framework for evaluating CAR T cell therapy efficacy and variability

DOI10.1016/j.mbs.2024.109141zbMATH Open1539.92065MaRDI QIDQ6539718

Chau Hoang, Jianjun Paul Tian, Tuan Anh Phan, Cameron J. Turtle

Publication date: 15 May 2024

Published in: Mathematical Biosciences (Search for Journal in Brave)

zbMATH Keywords

stochastic modelingstopping timeergodic distributionCAR-T cell therapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) Applications of stochastic analysis (to PDEs, etc.) (60H30)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• Stochastic modeling of tumor progression and immune evasion
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
• Basic stochastic model for tumor virotherapy
• Deterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomas
• Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity
• Dynamics of cholera epidemic models in fluctuating environments

Related Items (1)

Mathematical model for IL-2-based cancer immunotherapy

This page was built for publication: A stochastic framework for evaluating CAR T cell therapy efficacy and variability

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6539718)